Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
XER
Xeris Biopharma Holdings, Inc.
Business Segments
Products & Services
Concentration risk percentage
Concentration risk percentage
Xeris Biopharma Holdings, Inc.
·
Products & Services
·
1 segment
·
Rolls up to
Concentration Risk %
Breakdown
Segments
Product revenue, net
View metric
Quarterly
Annual
TTM
Segment
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q1 '26
Product revenue, net
96%
97%
95%
1%
97%
96%
97%
98%
Total
—
—
—
—
—
—
—
—